表紙
市場調査レポート

世界の遺伝子検査市場の見通し

Global Genetic Testing Market Outlook 2022

発行 RNCOS E-Services Pvt. Ltd. 商品コード 270811
出版日 ページ情報 英文 150 Pages
即納可能
価格
本日の銀行送金レート: 1USD=102.06円で換算しております。
Back to Top
世界の遺伝子検査市場の見通し Global Genetic Testing Market Outlook 2022
出版日: 2016年07月01日 ページ情報: 英文 150 Pages
概要

当レポートでは、世界の遺伝子検査市場について調査分析し、市場情勢に焦点を当てて、促進要因、新興部門、規制の枠組みについて検証し、遺伝子検査の応用、企業リストなども含め、体系的な情報を提供しています。

第1章 アナリストの見解

第2章 調査手法

第3章 遺伝子検査の概要

  • 応用と利点
  • 手法
  • 遺伝子検査所:アンメットニーズの分析

第4章 世界の遺伝子検査市場の概要

  • 促進因子
  • 課題
  • 機会
  • 動向

第5章 世界の遺伝子検査市場の見通し

第6章 世界の遺伝子検査市場:用途別

  • 癌検査
  • 診断検査
  • 新生児スクリーニング
  • 予測・発症前検査
  • 出生前検査
  • その他

第7章 世界の遺伝子検査市場:疾患別

  • アルツハイマー病
  • 嚢胞性線維症
  • ダウン症
  • その他

第8章 世界の遺伝子検査市場:地域別

  • 北米
  • 欧州
  • アジア太平洋地域
  • その他の地域

第9章 遺伝子検査の規制

第10章 M&A

第11章 企業プロファイル

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次

The advent of genetic tests has revolutionized the molecular diagnostics and cytogenetic industry. It is one of the most rapidly growing segments in molecular diagnostics industry, which helps in delivering customized health services or personalized medicine. The share of genetic testing is incessantly increasing in the market. Growing awareness about genetic testing, technological advances in genetic sequencing, and rising incidences of genetic diseases especially cancer are some of the major factors propelling the genetic testing market.

The report “Global Genetic Testing Market Outlook 2022” provides a detailed analysis of the genetic testing market. The report also provides an insight regarding the current and future prospective of the market. This report covers the major trends and drivers, and their impact on the market. The report also discusses some of the restraints that can hinder the growth of the market, as well as rising opportunities which can provide new dimensions to the industry.

The segmentation of genetic testing markets has been done in the report on the basis of applications, diseases, and geographical regions.

Based on application, the genetic testing market is divided into Diagnostic Testing, Newborn Screening, Prenatal Testing, Carrier Screening, and Others. Diagnostic testing and Newborn screening are the major application areas of genetic testing industry. The large shares of these applications can be attributed to presence of huge players in the segment, and to rising number of genetic tests performed for this purpose. The Carrier Testing market is expected to witness the highest growth during 2016-2022. This growth is likely to be driven by the huge population opting for carrier screening of cystic fibrosis, exhibiting unprecedented rise in the US. The report provides current and forecasted market for each of the application areas of Genetic Testing.

The major disease profiles/conditions for which Genetic Testing is used include Alzheimer's Disease, Cystic Fibrosis, Cancer, Down Syndrome, and Others. Cancer accounts for largest share amongst the diseases for which genetic testing is done. This large share can be attributed to the rising prevalence of cancer, which is expected to increase as the global population ages. Approximately 75-80% of all cancers are diagnosed in people aged 55 or older, and this pattern is expected to increase by 2020. The report provides current and forecasted market for each of the genetic conditions of Genetic Testing.

Moreover, the report also contains markets for the major regions including North America, Europe, Asia Pacific, and Rest of the World. North America contributes the largest share in the global genetic testing market, followed by Europe. Presence of major players, increased awareness and higher disposable income, are some of the prominent factors that have led to North America being the market leader. The Asia-Pacific market is expected to witness the highest growth during 2016-2022. The major reasons for the high growth are the increasing per capita income and gradual development of healthcare sector in countries, such as India and China . North America and Europe are expected to grow at modest rate due to launch of new and innovative products in these market.

The company profiles segment in this report is entirely devoted to profiling leading companies of the genetic testing industry including some major players like Abbott Laboratories, Roche Diagnostics, Myriad Genetics, Inc., Thermo Fisher Scientific, Inc., Hologic, Inc., Cepheid, Agilent Technologies and QIAGEN. This segment provides you access to the new launched products, recent developments, and strengths and weaknesses of these companies to deliver a clear understanding/view of the competitive landscape. Overall, the report will prove to be a complete source of knowledge and analysis for clients and potential investors.

Table of Contents

1. Analyst View

2. Research Methodology

3. Genetic Testing Overview

  • 3.1. Applications and Advantages
  • 3.2. Methods
  • 3.3. Genetic Testing Laboratories - Unmet Need Analysis

4. Industry Overview

  • 4.1. Drivers
    • 4.1.1. Rising Incidence of Chronic Diseases
    • 4.1.2. Growth in Ageing Population
    • 4.1.3. Increasing Government Initiatives
    • 4.1.4. Rising Investments in Genetic Testing Market
    • 4.1.5. Incessant Launch of New Genetic Tests
  • 4.2. Challenges
    • 4.2.1. Low Awareness for Genetic Testing in Developing Countries
    • 4.2.2. High Cost of Genetic Tests
    • 4.2.3. Varying Reimbursement Policies
    • 4.2.4. Ethical and Policy Issues
  • 4.3. Opportunities
    • 4.3.1. Next-Generation Sequencing (NGS)
    • 4.3.2. Non-Invasive Prenatal Testing (NIPT)
    • 4.3.3. Whole Genome Sequencing (WGS) for Cancer
    • 4.3.4. Personalized Medicine
  • 4.4. Trends
    • 4.4.1. Genetic Testing in Oncology: Gaining Momentum
    • 4.4.2. Strong Demand for Pharmacogenomics
    • 4.4.3. At-Home DNA Tests or Direct-to-consumer (DTC) Genetic Tests

5. Global Genetic Testing Market Outlook

6. Global Genetic Testing Market by Application

  • 6.1. Carrier Testing
  • 6.2. Diagnostic Testing
  • 6.3. New Born Screening
  • 6.4. Predictive & Pre-Symptomatic Testing
  • 6.5. Prenatal Testing
  • 6.6. Others

7. Global Genetic Testing Market by Disease

  • 7.1. Alzheimer's Disease
  • 7.2. Cystic Fibrosis
  • 7.3. Cancer
  • 7.4. Down Syndrome
  • 7.5. Others

8. Global Genetic Testing Market by Geography

  • 8.1. North America
  • 8.2. Europe
  • 8.3. Asia Pacific
  • 8.4. Rest of the World (RoW)

9. Genetic Testing Regulations

10. Mergers & Acquisitions

11. Company Profiles (Overview, Product Offering, Financials, Developments, Strength & Weakness)

  • 11.1. Abbott Laboratories
  • 11.2. Roche Diagnostics
  • 11.3. Myriad Genetics, Inc.
  • 11.4. Thermo Fisher Scientific, Inc.
  • 11.5. Agilent Technologies, Inc.
  • 11.6. Hologic, Inc.
  • 11.7. Illumina, Inc.
  • 11.8. QIAGEN N.V.
  • 11.9. Cepheid
  • 11.10. Quest Diagnostics

List of Figures:

  • Figure 4-1: Global - Population above 60 Years (Billion), 2013 & 2050
  • Figure 4-2: Organizational Transformation to Support Personalized Medicine
  • Figure 5-1: Global - Genetic Testing Market (Billion US$), 2015-2022
  • Figure 5-2: Number of Disorders, Genes, Labs for Genetic Testing, 2012-2015
  • Figure 5-3: Number of Genetic Tests Performed, 2012-2015
  • Figure 5-4: Global - Breakup of Genetic Tests by Type (%)
  • Figure 6-1: Global - Genetic Testing Market Segmentation by Applications (%), 2016
  • Figure 6-2: Global - Genetic Testing Market Segmentation by Applications (%), 2022
  • Figure 6-3: Global - Carrier Testing Market (Billion US$), 2015-2022
  • Figure 6-4: Global - Diagnostic Testing Market (Billion US$), 2015-2022
  • Figure 6-5: Global - Newborn Screening Market (Billion US$), 2015-2022
  • Figure 6-6: Global - Predictive & Pre-Symptomatic Testing Market (Billion US$), 2015-2022
  • Figure 6-7: Global - Prenatal Testing Market (Billion US$), 2015-2022
  • Figure 6-8: Global - Other Application Market (Billion US$), 2015-2022
  • Figure 7-1: Global - Genetic Testing Market Segmentation by Disease (%), 2016
  • Figure 7-2: Global - Genetic Testing Market Segmentation by Disease (%), 2022
  • Figure 7-3: Global - Alzheimer's Disease Testing Market (Billion US$), 2015-2022
  • Figure 7-4: Global - Cystic Fibrosis Testing Market (Billion US$), 2015-2022
  • Figure 7-5: Global - Cancer Testing Market (Billion US$), 2015-2022
  • Figure 7-6: Global - Down Syndrome Testing Market (Billion US$), 2015-2022
  • Figure 7-7: Global - Other Disease Market (Billion US$), 2015-2022
  • Figure 8-1: Global - Genetic Testing Market Segmentation by Geography (%), 2016
  • Figure 8-2: Global - Genetic Testing Market Segmentation by Geography (%), 2022
  • Figure 8-3: North America - Genetic Testing Market (Billion US$), 2015-2022
  • Figure 8-4: North America - Breakup of Genetic Test by Type (%)
  • Figure 8-5: Europe - Genetic Testing Market (Billion US$), 2015-2022
  • Figure 8-6: Europe - Breakup of Genetic Test by Type (%)
  • Figure 8-7: Asia-Pacific - Genetic Testing Market (Billion US$), 2015-2022
  • Figure 8-8: Asia-Pacific - Breakup of Genetic Test by Type (%)
  • Figure 8-9: Rest of the World - Genetic Testing Market (Billion US$), 2015-2022
  • Figure 8-10: Rest of the World - Breakup of Genetic Test by Type (%)
  • Figure 9-1: Genetic Testing Regulatory Agencies
  • Figure 11-1: Abbott Laboratories - Revenue Breakup by Segments (%), 2015
  • Figure 11-2: Abbott Laboratories - Revenue Breakup by Geography (%), 2015
  • Figure 11-3: Roche Holding - Revenue Breakup by Segments (%), 2015
  • Figure 11-4: Myriad Genetics - Revenue Breakup by Segments (%), 2015
  • Figure 11-5: Thermo Fisher Scientific Inc. - Revenue Breakup by Segments (%), 2015
  • Figure 11-6: Thermo Fisher Scientific Inc. - Revenue Breakup by Geography (%), 2015
  • Figure 11-7: Agilent - Revenue Breakup by Segments (%), 2015
  • Figure 11-8: Agilent - Revenue Breakup by Geography (%), 2015
  • Figure 11-9: Hologic - Revenue Breakup by Segments (%), 2015
  • Figure 11-10: Hologic - Revenue Breakup by Geography (%), 2015
  • Figure 11-11: Illumina - Revenue Breakup by Geography (%), 2015
  • Figure 11-12: QIAGEN N.V. - Revenue Breakup by Segments (%), 2015
  • Figure 11-13: QIAGEN N.V. - Revenue Breakup by Geography (%), 2015
  • Figure 11-14: Cepheid - Revenue Breakup by Segments (%), 2015
  • Figure 11-15: Cepheid - Revenue Breakup by Geography (%), 2015
  • Figure 11-16: Quest Diagnostics - Revenue Breakup by Segments (%), 2015

List of Tables:

  • Table 4-1: FDA Approved Pharmacogenomic Biomarkers
  • Table 4-2: Key DTC Genetic Testing Companies by Category
  • Table 4-3: Key Test Areas Offered in DTC Genetic Testing Segment
  • Table 5-1: Global - Number of Disorders, Genes & Laboratories for Genetic Testing
  • Table 8-1: North America - Number of Disorders, Genes & Laboratories for Genetic Testing
  • Table 8-2: Europe - Number of Disorders, Genes & Laboratories for Genetic Testing
  • Table 8-3: Asia-Pacific - Number of Disorders, Genes & Laboratories for Genetic Testing
  • Table 8-4: Rest of the World - Number of Disorders, Genes & Laboratories for Genetic Testing
  • Table 11-1: Abbott Laboratories - Key Gene Based Products
  • Table 11-2: Abbott Laboratories - Financial Performance (Million US$), 2013-2015
  • Table 11-3: Roche Molecular Diagnostics - Key Gene Based Products
  • Table 11-4: Roche Holding - Financial Performance (Million US$), 2013-2015
  • Table 11-5: Myriad Genetics - Key Gene Based Products
  • Table 11-6: Myriad Genetics - Financial Performance (Million US$), 2013-2015
  • Table 11-7: Thermo Fisher Scientific Inc. - Key Gene Based Products
  • Table 11-8: Thermo Fisher Scientific Inc. - Financial Performance (Million US$), 2013-2015
  • Table 11-9: Agilent - Key Gene Based Products
  • Table 11-10: Agilent - Financial Performance (Million US$), 2013-2015
  • Table 11-11: Hologic - Key Gene Based Products
  • Table 11-12: Hologic - Financial Performance (Million US$), 2013-2015
  • Table 11-13: Illumina - Key Gene Based Products
  • Table 11-14: Illumina - Financial Performance (Million US$), 2013-2015
  • Table 11-15: QIAGEN N.V. - Key Gene Based Products
  • Table 11-16: QIAGEN N.V. - Financial Performance (Million US$), 2013-2015
  • Table 11-17: Cepheid - Key Gene Based Products
  • Table 11-18: Cepheid - Financial Performance (Million US$), 2013-2015
  • Table 11-19: Quest Diagnostics - Key Gene Based Products
  • Table 11-20: Quest Diagnostics - Financial Performance (Million US$), 2013-2015
Back to Top